Areteia Therapeutics, Inc. research brief

CIK 1937542 Copy CIK

Generated Nov. 2, 2026, 12:10 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: CHAPEL HILL NC. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Feb. 21, 2025 · D/A · 0001937542-25-000001 · Source evidence

  Reported offering amount: 445000000 USD. Reported amount sold: 360000020 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Areteia Therapeutics, Inc. research brief,” CIK 1937542, retrieved Nov. 2, 2026, 12:10 p.m.. Cite the specific accessions used. No amounts have been summed.